Expression of human immunodeficiency virus genes using baculovirus expression system

被引：2

作者：

Yong Kang C. ^{[1
]}

机构：

[1] Faculty of Science, Western Science Centre, University of Western Ontario, London, N6A 5B7, ON

来源：

Molecular Biotechnology | 1997年 / 8卷 / 2期

基金：

英国医学研究理事会;

关键词：

AIDs; baculovirus expression system; gene expression; Human immunodeficiency virus; vaccines; viral proteins;

D O I：

10.1007/BF02752262

中图分类号：

学科分类号：

摘要：

The structural protein genes of HIV-1 and HIV-2 have been expressed inSpodoptera frugiperda (SF) cells using baculovirus expression system. The noncoding flanking sequences of HIV structural genes were removed and a putative ribosome binding site was placed in front of the open reading frame of each gene by using crossover linker mutagenesis. The coding sequences of thegag, pol, env, andvif proteins were inserted intoAutographa californica nuclear polyhedrosis virus (AcNPV) so that HIV genes were under the control of the AcNPV polyhedrin promoter. All recombinant AcNPV-infected SF cells express high levels of HIV structural proteins. Detailed strategies of recombinant AcNPV construction for high level protein expression are presented. © 1997, Humana Press Inc.

引用

页码：173 / 187

页数：14

共 24 条

[1]

Weber J.N., Clapham P.R., Weiss R.A., Et al., Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis, Lancet, 1, pp. 119-122, (1987)

[2]

Groopman J.E., Benz P.M., Ferriani R., Mayer K., Allan J.D., Weymouth L.A., Characterization of serum neutralization response to the human immunodeficiency virus HIV, AIDS Res. Human Retroviruses, 3, pp. 71-86, (1987)

[3]

Devash Y., Reagan K., Wood D., Turner J., Parrington M., Kang C.-Y., Antibodies against AIDS proteins, Nature (Lond.), 345, (1990)

[4]

Lyerly H.K., Reed D.L., Matthews T.J., Langlois A.J., Ahearner P.A., Petteway S.R., Weinhold K.J., Anti-gp 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC, AIDS Res. Human Retroviruses, 3, pp. 409-422, (1987)

[5]

Rook A.H., Lane H.C., Folks T., McCoy S., Alter H., Fauci A.S., Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells, J. Immunol., 138, pp. 1064-1067, (1987)

[6]

Ljunggren K., Karlson A., Fenyo E.M., Jondal M., Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection, Clin. Exp. Immunol., 75, pp. 184-189, (1989)

[7]

Bender B.S., Auger F.A., Quinn T.C., Redfield R., Gold J., Folks T.M., Impaired anti-body-dependent cell-mediated cytotoxic activity in patients with the acquired immunodeficiency syndrome, Clin. Exp. Immunol., 64, pp. 166-172, (1986)

[8]

Wisecarver J.T., Bechtold T., Lipscomb H., Davis J., Collins M., Purtilo D., Sonnabend J.A., Comparison of antibody-dependent cell-mediated cytotoxicity and natural killer activities of peripheral blood mononuclear cells from patients at risk for acquired immunodeficiency syndrome, AIDS Res., 1, pp. 347-352, (1984)

[9]

Katz J.D., Mitsuyasu R., Gottlib M.S., Lebow L.T., Bonavida B., Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex, J. Immunol., 139, pp. 55-60, (1987)

[10]

Gotch F., McMichael A., Smith G., Moss B., Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes, J. Exp. Med., 165, pp. 408-416, (1987)

← 1 2 3 →